Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02330315 · ClinicalTrials.gov registry record · NA

Effects of tDCS and tUS on Pain Perception in OA of the Knee

A NA study, sponsored by Spaulding Rehabilitation Hospital.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT02330315: Completed NA study, sponsored by Spaulding Rehabilitation Hospital.

NCT02330315 is a NA study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02330315, a NA study, has completed, sponsored by Spaulding Rehabilitation Hospital.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) on pain perception and functional limitations in people with osteoarthritis of the knee. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.

Primary Outcome

Changes in the Visual Analogue Scale (VAS) for pain will be measured in order to determine whether anodal transcranial direct current stimulation in conjunction with transcranial ultrasound (applied in a diagnostic mode) is effective in reducing pain in subjects with osteoarthritis knee pain. The investigators will also look at changes in the Von Frey assessment and pain pressure threshold (PPT).

Interventions

  • DEVICE transcranial direct current stimulation (tDCS)
  • DEVICE transcranial ultrasound (TUS)

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2015-03
Est. Completion 2016-08
Phase NA
Spaulding Rehabilitation Hospital

101 total trials

What the finished NCT02330315 record still lists

NCT02330315 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which transcranial direct current stimulation (tDCS) is the first listed.

NCT02330315 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02330315 about?

NCT02330315 is a clinical study titled "Effects of tDCS and tUS on Pain Perception in OA of the Knee". The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) on pain perception and functional limitations in people with osteoarthritis of the knee. The investigators hypothesize that there will be a decr...

What is the current status of trial NCT02330315?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-03. Estimated completion is 2016-08.

What interventions are being tested in trial NCT02330315?

The interventions under investigation include: transcranial direct current stimulation (tDCS) (DEVICE), transcranial ultrasound (TUS) (DEVICE).

Who is sponsoring clinical trial NCT02330315?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02330315's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02330315, the US trial registry maintained by the National Library of Medicine. NCT02330315 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.